nj neuro
for the patient for the healthcare provider research post grad physician referal about us

logos

DYSTONIA
Philip A. Hanna, M.D.
Parkinson's Disease and Movement Disorders Center
New Jersey Neuroscience Institute
Edison, New Jersey

Dystonia is a neurologic condition characterized by involuntary sustained or intermittent, patterned, repetitive muscle contractions, frequently resulting in twisting, flexing or extending (e.g. writer's cramp, retrocollis), pulling, squeezing movements or abnormal postures. Typically, dystonia begins in a single body part (focal dystonia), such as the hand, neck or eyelids, and then may spread to adjacent body areas (segmental dystonia). Blepharospasm is a focal dystonia with involuntary eye closure secondary to contractions of the eyelids and eyebrows. Oromandibular dystonia, when associated with clenching (trismus) and grinding of teeth (bruxism), may result in dental and temporal-mandibular joint (TMJ) difficulties. Cervical dystonia affects neck muscles and is commonly called "torticollis" (rotation of head). However, individuals may also have flexion, extension or tilting of the head. Spasmodic dysphonia is a focal dystonia of the larynx, resulting in a strained voice pattern which may be interrupted by voiceless pauses uncontrollable pitch breaks or voiceless pauses (adductor form) or a breathy, soft voice (abductor form). Cervical dystonia is the most common form of dystonia seen in specialized clinics, though "writer's cramp" (a task-specific dystonia) is likely more common in the general population. Dystonia may spread to involve the legs, trunk and other body parts (generalized dystonia), particularly if the onset is during childhood. Hemidystonia refers to dystonia which is confined to only one half of the body. This form of dystonia often has an identifiable cause such as head trauma, stroke, tumor, or other pathology.
There have been recent discoveries including the identification of a gene for idiopathic Jewish and non-Jewish autosomal dominantly transmitted dystonia in the q34 region of chromosome 9. Not all dystonias are of genetic origin as some are sporadic and others are due to specific causes, including Wilson's disease, neurodegenerative disorders, toxins and both dopaminergic and anti-dopaminergic drugs. 
The treatment of this conditions has dramatically improved, largely due to the use of botulinum toxin (BTX). About a third of patients benefit from medications. A small group of patients with childhood onset dystonia improve markedly with levodopa. Surgical techniques, such as local denervation, thalamatomy and pallidotomy, are only used if other treatment modalities have not provided satisfactory benefit.

Dystonia Medical Research Foundation
One East Wacker Drive, Suite 2430
Chicago, IL. 60601-1905
(312) 755-0198 

Hanna PA, Cardoso F, Jankovic J. Basal Ganglia and Movement Disorders. In: Rolak LA, ed. Neurology Secrets, 2nd ed. New York: Hanley and Belfus, 1998:137-169.

Jankovic J, Fahn S. Dystonic syndromes. In Jankovic J, Tolosa E., eds. Parkinson's disease and movement disorders, 3rd edition. Baltimore, William & Wilkins, 1998:513-551.